What is severe aortic stenosis? - Clinical Solutions

Clinical Solutions

What Is Severe Aortic Stenosis?

The average thickness of the aortic valve is only 0.3 mm. Yet the aortic valve will be opened and closed nearly 2 billion times in a person's lifetime, consequently aortic valve is likely to deteriorate. Additionally, bacterial infection, aging and various other factors could also threaten the health of aortic valve, resulting in valve stenosis.

When aortic valve stenosis occurs, the valve becomes hard, inflexible, and cannot be fully opened and closed, the natural pumping mechanism of blood is affected, resulting in insufficient blood output. The heart also has to increase its power just to pump out the same amount of blood. Over time, this long-term "overworked" state will permanently damage the heart muscle, causing heart failure. Heart failure could seriously affect patient’s daily activities, even lead to death.

0.3mm

Mean thickness of the aortic valve
20billion times

Opening and closing times of the aortic valve

Clinical Solutions

Treatment options for severe aortic stenosis

Currently, there are only two treatment options for aortic stenosis, first is through surgical means, the second is through taking medicine. However, taking medicine is not a "root cause" solution for severe aortic stenosis, and only relieves the symptoms, in some cases, taking medicine could even be harmful. Therefore, surgical treatment has become the main treatment for more patients with aortic stenosis. There are two main surgical treatments for aortic stenosis, namely traditional open heart surgical treatment, and the latest minimally invasive interventional treatment.

Surgical Aortic Valve Replacement (SAVR)

In the surgical treatment, anesthesia should be carried out first, cardiopulmonary bypass should be established in the state of cardiac arrest. A 20cm incision in the chest was made and the heart was cut. The diseased valve was removed and replaced with artificial valve.

The whole operation time and postoperative recovery time are relatively long, some elderly patients with weak body conditions, or poor cardiac function may not be able to withstand surgical operation; after surgery, patients may also suffer the risk of stroke, myocardial infarction, and even death.
Transcatheter Aortic Valve Implantation (TAVI)

The treatment only requires a minimally invasive incision to deliver the artificial valve to the diseased aortic valve through a catheter and release it, replacing the damaged valveto restore the normal opening and closing function of the heart valve and smooth blood circulation.

Surgical Aortic Valve Replacement (SAVR)

Transcatheter Aortic Valve Implantation (TAVI)

Clinical Solutions

Minimally Invasive Option for Severe Aortic Stenosis: TAVI

During TAVI, the bioprosthetic valve is fully folded into the catheter, which then passes through the aorta into the heart.

Common approaches for TAVI are transapical , transfemoral artery, transsubclavian artery, and transascending aorta.

Through the imaging and delivery system, the physician delivers the catheter to the diseased valve, then gradually release the valve through the automatic handle after positioning. Figure 2 shows the valve in release. When the valve is completely released, the biological valve fully unfolds in the diseased valve, and replaces the function of the original valve in the patient's body.

First Step

The valve is folded and placed in the catheter. The catheter and the folded valve passes through the artery to the diseased aortic valve.
Second Step

The physician release the valve from the catheter and push the diseased area of the aortic valve aside. To ensure accurate positioning and placement of the new valve, The physician will use special X-ray equipment.
Third Step

Once installed in place, the new valve will immediately start to work and restore healthy blood flow. After the test confirms that the new valve is functioning properly, the physician will remove the catheter, close the incision, and transfer the patient to the rehabilitation area.

Privacy settings

This website may store cookies on your browser. Cookies are mostly used to make the website work asyou expect it to. No cookie will directly identify you, but it can give you a more personalized browsingexperience.

CardioFlow Medtech respects your privacy rights, so you can block some types of cookies. Technically non-essentialcookies and tracking mechanisms, that enable us to provide you with customized offers (marketingcookies), are only used if you have given prior consent to such use.

Strictly necessary cookies

Consent to marketing cookies

By clicking "Save", only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.

互联网药品信息服务资格证书编号：（沪）-非经营性 - 2024 - 0135

“MicroPort CardioFlow”及“ are registered trademarks of MicroPort CardioFlow Medtech Corporation.